Myrexis (MYRX -2.8%) is down today after after reporting a wider FQ4 loss and saying it's...

|By:, SA News Editor

Myrexis (MYRX -2.8%) is down today after after reporting a wider FQ4 loss and saying it's suspended any further development of its lead drug candidate Azixa.